Taigo Kato, Yuzo Nakano, Fumiya Hongo, Hidenori Katano, Tomoaki Miyagawa, Kosuke Ueda, Haruhito Azuma, Masahiro Nozawa, Nobuyuki Hinata, Junichi Hori, et al. Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART). International Journal of Urology. 2024
Yuki Kohada, Keisuke Goto, Ryo Tasaka, Kensuke Nishida, Kunihiro Hashimoto, Hideo Iwamoto, Tomoya Hatayama, Tomoki Furutani, Shunsuke Miyamoto, Kohei Kobatake, et al. Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study. Clinical genitourinary cancer. 2023
Tomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, Takahiro Osawa, Nobuyuki Hinata, Shingo Hatakeyama, Kazuyuki Numakura, Kosuke Ueda, Takahiro Kimura, Masayuki Takahashi, et al. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Scientific reports. 2023. 13. 1. 20629-20629
Yasuyuki Akasaka, Shun Hasei, Yukino Ohata, Machi Kanna, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama, Hiraku Ono, Akio Matsubara, et al. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells. International Journal of Molecular Sciences. 2023
Takafumi Fukushima, Keisuke Goto, Tetsutaro Hayashi, Kenichiro Ikeda, Tomoya Hatayama, Ryoken Yamanaka, Kyosuke Iwane, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, et al. Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study. Japanese journal of clinical oncology. 2023